MLOCT Octopus Biosafety SA

0.1371USD0.1250 EUR · EPA0.00%Mkt Cap: 17.43M USDP/E: —

Octopus Biosafety SA engages in designing, manufacturing, and marketing of mobile, autonomous, intelligent, and modular robots for poultry industry in France and internationally. It offers XO, a continuous litter treatme…

Key Statistics

Company
Market Cap17.43M USD
Enterprise Value—
Revenue (TTM)422.39K USD
Gross Profit-368.85K USD
Net Income (TTM)-722.91K USD
Revenue/Share0.03 USD
Last Price0.1371 USD
Fiscal Year EndDec 2024
MR Quarter—
Employees6
CountryFR
SectorTechnology
IndustryComputer Hardware
ISINFR0013310281
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S41.26
P/B-2.84
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.13052% of range0.4168
52W High0.4168 USD
52W Low0.1305 USD
Profitability
Gross Margin-642.91%
Oper. Margin-217.46%
EBITDA Margin-40.18%
Profit Margin-1260.05%
ROE100.48%
ROA-134.66%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.83
Current Ratio0.32
Quick Ratio0.29
Book Value/Sh-0.05 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.127.13M
Float882.62K
Insiders—
Institutions—
Technical
SMA 500.1601 (-14.3%)
SMA 2000.1855 (-26.1%)
Beta-0.02
S&P 52W Chg12.00%
Avg Vol (30d)1.22K
Avg Vol (10d)1.45K
Technical Indicators
RSI (14)41.5
MACD-0.0059
MACD Signal-0.0042
MACD Hist.-0.0017
BB Upper0.1808 USD
BB Middle0.1534 USD
BB Lower0.1260 USD
BB Width35.72%
ATR (14)0.0075 USD
Vol Ratio (20d)0.00x

About Octopus Biosafety (EPA: MLOCT)

›

Octopus Biosafety (EPA: MLOCT) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Computer Hardware industry, part of the Technology sector, and reports about 6 employees.

The shares were at 0.1250 EUR on 18 November 2026, down 60.4% over 52 weeks. Its 52-week range is 0.1190 EUR to 0.3800 EUR: the price is 67.1% below the high and 5.0% above the low.

Its market capitalisation is 15.89M EUR.

Octopus Biosafety reports return on equity of 100.5% and an operating margin of -217.5%.

Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.